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Abstract 
 
The behaviour of cells cultured within three-dimensional (3D) structures rather than 
onto two-dimensional (2D) culture plastic more closely reflects their in vivo 
responses. Consequently, 3D culture systems are becoming crucial scientific tools in 
cancer cell research. We used a novel 3D culture concept to assess cell-matrix 
interactions implicated in cancerogenesis: a synthetic hydrogel matrix equipped with 
key biomimetic features, namely incorporated cell integrin-binding motifs (e.g. RGD 
peptides) and the ability of being degraded by cell-secreted proteases (e.g. matrix 
metalloproteases). As a cell model, we chose epithelial ovarian cancer, an aggressive 
disease typically diagnosed at an advanced stage when chemoresistance occurs. Both 
cell lines used (OV-MZ-6, SKOV-3) proliferated similarly in 2D, but not in 3D. 
Spheroid formation was observed exclusively in 3D when cells were embedded 
within hydrogels. By exploiting the design flexibility of the hydrogel characteristics, 
we showed that proliferation in 3D was dependent on cell-integrin engagement and 
the ability of cells to proteolytically remodel their extracellular microenvironment. 
Higher survival rates after exposure to the anti-cancer drug paclitaxel were observed 
in cell spheroids grown in hydrogels (40-60%) compared to cell monolayers in 2D 
(20%). Thus, 2D evaluation of chemosensitivity may not reflect pathophysiological 
events seen in patients. Because of the design flexibility of their characteristics and 
their stability in long-term cultures (28 days), these biomimetic hydrogels represent 
alternative culture systems for the increasing demand in cancer research for more 
versatile, physiologically relevant and reproducible 3D matrices. 
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1. Introduction 
 
A growing body of evidence suggests that three-dimensional (3D) models, in contrast 
to two-dimensional (2D) flat, conventional culture plastic, replicate more accurately 
the actual microenvironment where cells reside in tissues; and therefore the behaviour 
of cells cultured in 3D will reflect more closely their in vivo responses [1-4]. 
Consequently, 3D culture models are becoming increasingly crucial research tools, in 
particular in cancer cell biology [5-7], as they are a bridge between traditional culture 
on plastic and in vivo experiments [8-10]. 
 
Currently, in vitro 3D culture models for cancer research include multicellular 
spheroids grown in suspension [11, 12] and cells embedded within naturally derived 
extracellular matrices (ECM) (e.g. reconstituted ECM-protein-based matrices for 
MatrigelTM [13-17], collagen gels [18, 19] and cell-secreted ECMs [20]). Although 
these 3D culture systems have profoundly revolutionised fundamental cancer research 
[2], they have experimental and interactive limitations. Multicellular spheroids grown 
as independent cell agglomerates in the absence of an ECM do not interact with their 
extracellular milieu and do not have physical resistance provided by the ECM [21]. 
The gold standard 3D matrix MatrigelTM and other naturally derived hydrogels have 
ECM-like biological properties, but their inherent characteristics offer limited design 
flexibility in fine-tuning different matrix properties (physical and biological) 
independently [22]. In addition, their relatively poor handling characteristics and 
batch-to-batch composition differences affect the reproducibility of experimental 
outcomes and comparative studies [4, 9]. 
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Emerging approaches in biomaterial sciences and regenerative medicine have focused 
on the development of synthetic hydrogels that mimic the key features of natural 
extracellular microenvironments due to flexible biochemical and biophysical 
characteristics [23-26]. As provisional matrices and drug delivery platforms in 
biomaterial-based regenerative medicine, these biomimetic hydrogels have 
demonstrated that they can be equipped with specific biological functionalities that 
influence cellular performance in vitro and in vivo [27-29]. In the context of cancer 
biology, cell–ECM interactions are fundamental to cancerogenesis and related 
signalling events [30-32]. The possibility of re-creating controlled extracellular 
microenvironments, characterised by cell-integrin binding sites and susceptibility to 
proteolytic remodelling, are key features of synthetic hydrogels that can be exploited 
to study cancer cell–ECM interactions. Such synthetic and defined matrices can 
overcome the limitations of naturally derived matrices. Hence, these attributes make 
biomimetic hydrogels an exciting alternative to the currently used 3D systems [26, 33, 
34]. 
 
Specifically, we used synthetic hydrogels that are formed from peptide-functionalised 
multiarm polyethylene glycol (PEG) macromolecules via the factor XIII (FXIII)-
catalysed cross-linking mechanism, a reaction occurring during fibrin clot formation 
in natural wound healing. Desired biological functions can be conferred on these 
matrices through stable and specific incorporation of peptides (e.g. the Arg-Gly-Asp 
(RGD) integrin-binding motif), and other proteins (e.g. growth factors) by means of 
the same cross-linking reaction and simultaneously with the gel formation [35, 36]. 
The sensitivity of these matrices to degradation by cell-secreted/activated proteases 
(e.g. matrix metalloproteinases (MMP)), can be precisely controlled by designing 
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MMP substrates within the hydrogel network [28, 29]. The matrix stiffness can be 
regulated by changing the polymer dry mass of the hydrogel, without changing their 
biological and biochemical characteristics [29, 36]. 
 
The aim of our study was to provide a proof of concept that this synthetic 3D platform 
offers a versatile cell culture model to analyse interactions crucial in cancer 
progression and anti-cancer drug resistance. We have hypothesised that the 
malleability of the hydrogel characteristics, in contrast to natural gold standard gels 
(e.g. MatrigelTM), may be exploited to dismantle complex cell–ECM interactions of 
cancerogenesis in vivo into more simple and defined questions trackable in an in vitro 
setting. We used two cell lines as cancer cell models – OV-MZ-6 [37] and SKOV-3 
[38] – both were derived from peritoneal ascites (fluid that surrounds the cancer in the 
abdominal cavity) of human epithelial ovarian carcinoma (EOC), an aggressive form 
of ovarian cancer typically diagnosed at an advanced stage. At this late disease stage, 
chemotherapy resistance occurs, for reasons as yet unknown [39]. The ability of both 
cancer cell lines, embedded within these synthetic hydrogels, to grow multicellular 
spheroids from single cells and their resistance to anti-cancer drugs compared to cell 
monolayers grown on conventional 2D plastic surfaces [40, 41] were investigated. 
The influences of extracellular microenvironment characteristics, achieved by 
systematic and independent alteration of the physical, biological and biochemical 
properties of these synthetic matrices, on the behaviour of the EOC cells cultured in 
3D were determined. 
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2. Materials and methods 
 
2.1. Abbreviations 
 
CLSM, confocal laser scanning microscopy; EOC, epithelial ovarian carcinoma; 
FXIII, factor XIII; MMP, matrix metalloproteinase; mab, monoclonal antibody; PFA, 
paraformaldhyde; PBE, phosphate-buffered EDTA; PEG, polyethylene glycol; RGD, 
Arg-Gly-Asp; SEM, scanning electron microscopy; TEM, transmission electron 
microscopy. 
 
2.2. Materials 
 
Cell culture reagents, rhodamine415-conjugated phalloidin, Alexa488-conjugated 
anti-mouse IgG, DAPI, PCR reagents, CyQuant® and AlamarBlue® assays were from 
Invitrogen. Amino acids, PFA, porcine gelatin, Brilliant Blue R, BSA, Sigmacote®, 
paclitaxel and monoclonal antibody (mab) anti-keratin 18 (#KS-B17.2) were from 
Sigma-Aldrich. Mab anti-keratin 8 (#M20) and anti-vimentin (#V9) were from 
Abcam. MMP-inhibitor GM6001 [Ilomastat], mab anti-α3-integrin (#P1B5) and anti-
β1-integrin (#P5D2) were from Chemicon. Recombinant MMP9 and triton X-100 
were from Calbiochem. Bradford™ assay and Brij-35 detergent were from Pierce. 
Reagents for SEM and TEM were from ProSciTech. RNeasy micro kit was from 
Qiagen. SYBR® Green PCR master mix was from AB Applied Biosystems. Mab anti-
E-cadherin (#HECD-1) was from Zymed Laboratories Inc. MMP9 activity assay was 
from GE Healthcare. 
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2.3. Cell lines 
 
The human epithelial ovarian cancer (EOC) cell line OV-MZ-6 was established from 
malignant ascites and cultured as reported previously [37]. The human epithelial 
ovarian serous adenocarcinoma cell line SKOV-3 derived from ascites fluid was 
obtained from American Type Culture Collection (ATCC) and cultured as 
recommended [38]. 
 
2.4. Preparation of PEG-based hydrogels for 3D cell cultures 
 
Polyethylene glycol (PEG)-precursors for factor XIII (FXIII)-catalysed hydrogel 
formation was engineered as reported previously [35, 36]. Hydrogel networks were 
formed in Tris-buffered saline buffer (TBS; 50 mM Tris-HCl, 50 mM CaCl2, pH 7.6) 
by thrombin-activated factor XIII (10.7 U/mL) cross-linking reaction of two 
precursors having complementary FXIII-substrates: i) PEG-Gln produced with 8-arm 
PEG (40kDa) end-functionalised with Gln-containing FXIII-substrate 
(NQEQVSPLERCG); ii) PEG-MMP-Lys formed from 8-arm PEG (40 kDa) end-
functionalised with the Lys-containing FXIII-substrate and MMP-sensitive site for 
proteolytic degradation of final hydrogels (FKGGGPQG↓IWGQERCG) [29]. To form 
non-degradable hydrogels, the precursor 8-PEG-MMP-Lys was replaced by 8-PEG-
noMMP-Lys in which the MMP-degradable substrate was substituted by a MMP-
insensitive sequence (FKGGGDQGIAGFERCG). Simultaneously, by means of the 
same reaction, the bio-functional peptide RGD, (NQEQVSPL-GRGDSPG, 50 μM), 
was stably incorporated into hydrogel networks. Cross-linking reactions were 
performed in sterile humidified atmosphere for 35 min at 37°C/5% (v/v) CO2. 
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Biomaterial stiffness was tuned using different polymer dry mass percentages 
(1.5/2.0/2.5% (w/v)) corresponding to different physicochemical properties (elastic 
shear modulus G’=241±19/637±93/1201±121 Pa) as described previously [42]. 
Human EOC cells were encapsulated within PEG-based hydrogel precursor solution 
(3.5x105 cells/mL). Immediately thereafter and prior to cross-linking, 20 μL of 
hydrogel precursor solution was sandwiched between two sterile, Sigmacote® pre-
treated, hydrophobic glass slides within 1.5 mm spacers. After polymerization at 
37°C/5% (v/v) CO2 for 35 min, hydrogel discs were removed from glass slides and 
immersed in culture media in 48-well plates. 3D cell cultures were performed over 12 
days in 300 μL culture media which was replaced every 3 days. For protease activity 
studies, the 3D hydrogels were then washed in phosphate-buffered saline (PBS) and 
further treated for 1 day with serum-free media prior to a fresh 1 day serum-free 
media collection for analysis. 
 
2.5. Detection of 2D/3D cell proliferation using CyQuant® and AlamarBlue® 
assays 
 
Three x104 cells in 100 µL culture media per well (8.3x103 cells/cm2) were cultured in 
2D in 96-well plates for 1-5 days or in 3D for 1, 4, 12 days, washed in PBS and frozen 
at -80°C until assayed. Preparation of the 3D samples for CyQuant® assays was 
performed as described earlier [42]. Briefly, 3D samples were digested with 
ProteinaseK (0.5 mg/mL) diluted in phosphate-buffered EDTA (PBE, pH 7.1) at 60°C 
overnight. Subsequently, 3D samples were treated with RNaseA (1.4 units/mL) for 1 
hr at room temperature (RT) in cell-lysis buffer supplemented with NaCl (180 mM) 
and EDTA (1 mM). Measurements of the DNA content by CyQuant® assays were 
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performed as reported previously [43] and fluorescent signals (excitation 485 nm, 
emission 520 nm) detected using a plate reader (BMG PolarStar). The provided λ 
DNA standard (10 ng to 2 μg/mL) was applied to calculate the n-fold change of DNA 
content per 2D/3D condition. 
For AlamarBlue® assays, 3.0x104 cells were cultured as above prior to the addition of 
the AlamarBlue® reagent (2D - 10% (v/v), 3D - 4% (v/v)) [43] and fluorescent signals 
(excitation 544nm, emission 590nm) detected as above. For each condition, three 
different biological assays were performed in triplicate. 
 
2.6. Cell survival post paclitaxel treatment 
 
One day after seeding of 2D cultures on 96-well plates, cells were treated with 
paclitaxel (0, 0.01, 1, 10, 100 nmol/L) for 3 days. Additionally, 2D monolayers 
treated for 3 days were cultured for another 3 days in fresh media. 7 or 14 days after 
3D culture, spheroids were treated with paclitaxel (10 nmol/L) for a further 7 or 14 
days. Cell spheroids grown for 7 days and treated for 7 days were also cultured for 
another 7 days in fresh media and CyQuant® and AlamarBlue® assays performed as 
described above. Cell survival was calculated using DNA content/metabolic activity 
as a percentage of fluorescence in non-treated cells. 
 
2.7. Confocal laser scanning microscopy (CLSM) of 2D/3D cultures 
 
EOC cells were grown to 80% confluent monolayers on sterile coverlips in 24-well 
plates. Samples were washed in PBS, fixed and permeabilized with 4% (w/v) 
paraformaldehyde (PFA)/PBS containing 0.2% (w/v) saponin for 30 min at RT. Then, 
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samples were washed once in glycine buffer (0.1 M glycine in PBS) followed by two 
washes in PBS and blocked in 1% (w/v) bovine serum albumin (BSA)/PBS for 30 
min at RT followed by incubation with primary (keratin 8 (1/100), keratin 18 (1/500), 
E-cadherin (1/200), vimentin (1/200), α3 (1/500) and β1 integrins (1/500)) and 
secondary antibodies (Alexa488-conjugated anti-mouse IgG (1/1,000)) in 1% (w/v) 
BSA/PBS each for 1 hr at RT. The secondary antibody only served as a negative 
control. F-actin filaments and nuclei were stained with 0.3 U/mL rhodamine415-
conjugated phalloidin and 2.5 µg/mL 4'-6-diamidino-2-phenylindole (DAPI) 
respectively in 1% (w/v) BSA/PBS. Immunofluorescence was visualized and 
photographed using a confocal microscope (SP5, Leica). 
After 12 days of 3D culture, F-actin filaments and nuclei were immunofluorescence 
stained and imaged by CLSM as described above except that 0.2% (v/v) triton X-100 
and 0.8 U/mL rhodamine415-conjugated phalloidin was used. Integrins were stained 
using mab directed to α3 (1/500) and β1 integrins (1/500) followed by a secondary 
Alexa488-conjugated anti-mouse IgG (1/1,000). Confocal images of cells spheroids 
were recorded using a motorized upright on a Leica SP5 CLSM. Typically z-stacks 
were acquired with a constant slice thickness of 2 µm reconstructing a cross-section 
profile of approximately 100-150 equidistant XY-scans using the Leica Microsystems 
LAS AF software (version 1.8.2 build 1465). For each condition, EOC cells grown 
within 3D hydrogels were visualized at three different positions and repeated three 
times. 
 
2.8. Software analyses of CLSM images 
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To quantify the distribution pattern of cell clusters, cluster number and volume, 3D 
CLSM images were quantitatively analysed using previously described methods [44-
46]. Single cell volumes, single cells grown as 3D cultures within PEG-based 
hydrogels imaged on day 1 by CLSM, were used to determine an appropriate 
threshold for image data to retain essential information and remove rogue 
fluorescence signals. A threshold of 1% was shown to retain the structures and give 
the optimal correlation with the nominal cell volume. One-to-one agreement of cell 
volumes is not possible, since CLSM introduces a significant aberration in the Z-
direction. For image processing and evaluation, 2D raw data was converted to 3D 
greyscale data for both DAPI and rhodamine phalloidin channels. The data was 
segmented at 1% and then a filter was applied to remove noise-related clusters from 
the data (clusters > 1000 voxels). The total number of clusters and individual cluster 
sizes (µm3) for a data set were then calculated, and from this data, total cluster volume 
and average cluster size in the image (by dividing total volume with total number of 
clusters) was measured. 
 
2.9. Time-lapse microscopy of 3D cultures 
 
3D hydrogels were glued onto 24-well plates with 5% (w/v) hydrogel solution and 
survival and formation of cell spheroids live imaged using a widefield microscope 
(Leica, AF6000 LX) under sterile humidified atmosphere at 37°C/5% (v/v) CO2 over 
6 days. Images were taken every hour. For each condition, EOC cells grown within 
3D hydrogels were visualized at five different positions and repeated three times. 
 
2.10. Scanning electron and transmission electron microscopy (SEM/TEM) 
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After 12 days of 3D culture, hydrogels were transferred into 24-well plates, washed, 
fixed (3% (w/v) glutaraldehyde, 0.1 M sodium cacodylate buffer, pH 7.4, 0.4 M 
sucrose osmotically adjusted in cacodylate buffer, calcium dichloride) and stored at 
4ºC. On analysis, samples were washed (0.1 M sodium cacodylate buffer, twice for 10 
min) and post-fixed in Dalton’s fixative (1% (w/v) osmium tetroxide in potassium 
dichromate), and stepwise dehydrated (70% ethanol, twice for 10 min; 90% ethanol, 
twice for 10 min; 100% ethanol, twice for 15 min; 100% amyl acetate, twice for 15 
min). Samples were critical point dried (Denton Vacuum critical point drying 
apparatus; Moorestown), coated with a thin layer of gold (BIORAD SC500 gold 
coater; Hercules) and imaged on a FEI Quanta 200 SEM (Hillsboro) operating at 10 
kV. 
After 12 days of 3D culture, hydrogels were fixed and post fixed as for SEM, with an 
additional treatment for 30 min in 1% uranyl acetate. Post dehydration in ascending 
series of ethanol and acetone (50% ethanol, twice for 15 min; 70% ethanol, twice for 
15 min; 90% ethanol, twice for 15 min; 90% acetone, twice for 20 min; 100% 
acetone, twice for 30 min) samples were embedded in Spurr epoxy resin. Ultrathin 
sections (~ 50nm) were cut (RMC MT7 ultramicrotome), stained with uranyl acetate 
and lead citrate, then imaged and photographed with a 1200EX TEM (JEOL) 
operating at 80 kV. 
 
2.11. Reverse transcription-polymerase chain reaction (RT-PCR) and 
quantitative RT-PCR (RT-qPCR) 
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RT-PCR analysis was performed as described previously [47]. Equal amounts of total 
RNA from cells cultured in 2D monolayers (extracted using Trizol) and as cell 
spheroids (extracted using an RNeasy micro kit) were treated with DNase 1, reverse 
transcribed using random hexamers and SuperScript III to prepare first strand cDNA 
samples. Gene specific primers used are listed in Supplementary Table 1. PCR for 
18S served as internal control; PCR without cDNA for each primer as negative 
control. PCR products were electrophoresed on a 2% (w/v) agarose gel and visualized 
by ethidium bromide staining using a gel documentation system (Syngene). RT-qPCR 
was performed as described previously [47] using cDNA samples (1/10) generated 
above. Gene specific primers used are listed in Supplementary Table 1. RT-qPCR was 
performed in triplicate using SYBR® Green chemistry on an ABI7300 thermal cycler 
(Applied Biosystems) according to the manufacturer's instructions. The relative 
standard curve method was used to quantify gene expression levels; CT values for 
respective samples were fitted onto a standard curve to obtain respective expression 
levels. Final gene expression data were reported after normalisation to that of 18S 
RNA. 
 
2.12. MMP-inhibition, quantitative MMP9 activity assay and zymography 
 
Three x104 cells in 100 µL culture media per well (8.3x103 cells/cm2) were cultured in 
2D on 96-well plates for 1-5 days. After 1 day culture, culture media was 
supplemented with 20 μM MMP-inhibitor GM6001 [Ilomastat] and replaced after 2 
days with fresh media with or without 20 μM MMP-inhibitor supplemented for 
another 2 days. After a total culture period of 5 days, CyQuant® assays were 
performed as described above. Similar inhibitory studies followed by CyQuant® 
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assays were performed in 3D over 12 days and culture media containing 20 μM 
MMP-inhibitor replaced every 3 days. Three different biological assays were 
performed in triplicate. 
To quantify endogenous (pro-form) and total (pro+active) MMP9 levels of cells 
grown in 2D as monolayers and in 3D as cell spheroids, the biotrak activity assay was 
performed according to the manufacturer’s instruction employing 100 µl of sample. 
To measure levels of MMP9, serum-free conditioned media was diluted (1/10). 
MMP9 activity was calculated by subtracting endogenous (pro-MMP9) levels from 
total (pro+active) levels. 
Gelatine zymography using serum-free conditioned media was performed as 
previously reported [48]. Total protein concentrations were determined using a 
Bradford™ assay kit according to manufacturer’s instructions with BSA standards. 
Equal amounts of protein (5 ng/mL) and recombinant MMP9 (20 ng/mL) were 
electrophoresed on 8% (v/v) polyacrylamide gels containing 1 mg/mL porcine 
gelatine under non-reducing conditions. Gelatinolytic activities were detected at 37 °C 
for ~20 h and visualized by staining with 0.25% (w/v) Brilliant Blue R. 
 
2.13. Statistical analysis 
 
Statistical analyses were carried out using an ANOVA and Student’s t-test with the 
software ‘R’ version 2.10.0. Results for all analyses with ‘P’ value less than 0.05 were 
considered to indicate statistically significant differences (* - P<0.05; ** - P<0.01; 
*** - P<0.001). 
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3. Results 
 
3.1. Cell spheroid formation within biomimetic hydrogels 
 
To replicate the in vivo behaviour of the EOC cell lines OV-MZ-6 and SKOV-3, we 
used synthetic hydrogels displaying key features of the natural ECM (e.g. cell-integrin 
binding sites and degradability by cell-secreted/activated proteases) as a 3D culture 
system and compared this to conventional monolayer cultures in 2D. EOC cells 
embedded within hydrogels formed cell spheroids, similar to those found in ascites 
fluid accumulated in the peritoneal cavity of patients diagnosed with advanced 
ovarian cancer [40, 49], whereas EOC cells cultured on traditional 2D culture plastic 
formed typical monolayers (Fig. 1A, B). Both EOC cell types had similar 8-fold 
increased DNA content when grown in 2D after 5 days. However, OV-MZ-6 (but not 
SKOV-3) cells grown as spheroids within hydrogels showed a similar proliferation 
rate to that seen in 2D which was significantly enhanced after 12 days (23-fold 
increased DNA content; 5-fold SKOV-3; Fig. 1C). Both cell lines expressed a similar 
pattern of epithelial (keratin 8/18, E-cadherin) and mesenchymal (vimentin) markers 
detected at both the mRNA and protein level (Fig. S1), thus indicating that these 
proliferative profiles reflect other more subtle differences than morphological 
changes. Time-lapse microscopy of live spheroid survival and formation of both cell 
lines over 6 days revealed that multicellular spheroids were formed from single cells 
(Supplementary movies A, B). Further investigation of differences between 2D and 
3D cultures revealed that mRNA expression of the cell surface receptors α3/α5/β1 
integrins and the protease MMP9 were significantly increased in 3D compared to 2D 
(Fig. 1D). Multicellular spheroid formation was also analysed by SEM depicting the 
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development of lamellipodia and ECM in 3D representative for the in vivo behaviour 
of EOC cells (Fig. 1E-H). 
 
3.2. The effect of matrix stiffness on cell spheroid formation 
 
Matrix stiffness has been shown to influence cell behaviour in 2D [50] and 3D [22, 
28, 29]. Exploiting the design flexibility characteristics of our 3D culture platform, we 
studied the effect of altered matrix stiffness on the response of EOC cell spheroids in 
3D. Stiffness of hydrogels was varied as a function of polymer dry mass and 
decreased from 2.5% (w/v) to 1.5% (w/v) corresponding to the mechanical properties 
decreasing from 1201±121 Pa to 241±19 Pa. Cell spheroids grown in 3D proliferated 
less within stiffer (G’=1201±121 Pa) hydrogels. This effect was more pronounced in 
RGD-functionalised hydrogels (Figure 2A). 3D reconstructions of CLSM images 
visualized differences in the shape of cell spheroids: irregular and scattered cell 
spheroids were formed in softer (G’=241±19 Pa) hydrogels, compact and smaller cell 
spheroids grew in stiffer hydrogels (Fig. 5B). Quantitative cluster analyses showed 
significantly more smaller/medium clusters (5-10/10-15x104 μm3) in stiff RGD-
functionalised hydrogels in contrast to more abundant larger clusters (>20x104 μm3, 
P=0.07) measured in soft hydrogels (Fig. 2C, D). No significant effect was observed 
in non-RGD-functionalised hydrogels, only a trend towards smaller clusters (<5x104 
μm3, P=0.08) in stiffer hydrogels (Fig. S3A). A medium polymer dry mass of 2.0% 
(w/v) corresponding to G’=637±93 Pa was chosen for the analysis of the biological 
and biochemical characteristics of hydrogels. 
 
3.3. The influence of integrin engagement on cell spheroid formation 
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Since integrin cell adhesion and signalling receptors play crucial roles not only in 
chemoresistance but also in cell spheroid formation, we investigated this aspect by 
comparing the behaviour of EOC cells cultured within hydrogels with and without the 
incorporated cell-integrin binding sequence RGD [35, 36, 49, 51, 52]. Non-RGD-
functionalised hydrogels led to a 13-fold change of DNA content of OV-MZ-6 cells 
spheroids after 12 days. Upon RGD-functionalisation (50 μM) of hydrogels cell 
spheroids proliferated up to 23-fold (Fig. 3A). The DNA content of SKOV-3 cell 
spheroids also increased 50% when grown within RGD-functionalised hydrogels (Fig. 
S3B). 3D reconstructions of CLSM images confirmed differences in cell growth with 
enhanced spheroid formation in RGD-functionalised hydrogels compared to 
hydrogels without RGD peptides (Fig. 3B). Immunofluorescent staining of α3/β1 
integrins illustrated a higher expression in cell spheroids grown in RGD-
functionalised hydrogels than in 2D (Fig. 3C). Quantitative cluster analyses 
demonstrated significantly enhanced cluster number upon RGD-incorporation 
compared to hydrogels without RGD peptides, but no significant difference in cluster 
volume and size (Fig. 3D, E). 
 
3.4. Importance of cell-mediated matrix remodelling in 3D 
 
The main feature of our 3D system is the possibility of modulating its characteristics 
flexibly and independently. Hence, we varied the biochemical properties of hydrogels, 
(i.e. their sensitivity to cell-secreted MMPs [28, 29, 36]) to assess the cell proteolytic 
machinery and to study its implication in ECM remodelling and consequent cancer 
progression [36, 48, 53, 54]. The proliferation of EOC cells within MMP-sensitive 
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hydrogels was 50% enhanced compared to MMP-insensitive hydrogels. Similarly, the 
growth of cell spheroids within MMP-sensitive hydrogels was significantly reduced 
by inhibition of MMP activity through a broad-spectrum MMP-inhibitor (GM6001, 
20 µM) added to the culture media (Fig. 4A). Control experiments using the same 
MMP-inhibitor in 2D when cells were grown as monolayers showed no effect on 
proliferation (Fig. S3C). 3D reconstructions of CLSM images depicted the influence 
of MMP-sensitivity of hydrogels and MMP-inhibition on cell spheroid formation 
(Fig. 4B). Quantitative cluster analyses revealed that MMP-sensitivity had a 
significant effect on total number but not volume of clusters whereas MMP-inhibition 
led to both smaller (<5x104 μm3) and fewer clusters (Fig. 4C). Without MMP-
inhibition of MMP-sensitive hydrogels, significantly more medium/large clusters 
(<10-15/>20x104 μm3) were formed. A significant number of larger clusters (>20x104 
μm3) were formed in MMP-insensitive hydrogels compared to MMP-sensitive 
hydrogels (Fig. 4C), confirmed by histograms including density plots (Fig. 4D). SEM 
analyses showed a more ordered or structured growth of cell spheroids in MMP-
sensitive hydrogels and that MMP-inhibition led to smaller colonies and cell debris 
(Fig. S3F). 
Total MMP9 production in conditioned media of cell spheroids in 3D, measured by a 
quantitative activity assay, was decreased independent from RGD-incorporation 
within hydrogels compared to cell monolayers in 2D. Endogenous (pro-)MMP9 levels 
did not change upon 3D culture (Fig. S3D). Zymography confirmed pro-MMP9 in 
conditioned media of cell spheroids grown within hydrogels independent from their 
MMP-sensitivity. The pro-MMP9 level was reduced after MMP-inhibition (Fig. S3E). 
 
3.5. Chemoresistance of cell spheroids within biomimetic hydrogels 
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Due to the long-term stability of hydrogels (28 days; Fig. S2), we sought to examine 
the chemoresistance of EOC cells grown as spheroids towards clinically used anti-
cancer drugs like paclitaxel. Paclitaxel is a microtubule-stabilizing agent mediating 
cell cycle arrest and apoptosis [55] that is used for treatment of advanced ovarian 
carcinomas. Treatment of monolayers of OV-MZ-6 cells (and SKOV-3 cells - data 
not shown) in 2D with paclitaxel (0.01-100 nmol/L) for 3 days inhibited cell survival 
and proliferation dramatically (Fig. 5A). A concentration, at which 20% survival of 
cell monolayers (10 nmol/L) was reached, was used to treat cell spheroids grown in 
3D. Cell survival and proliferation, as measured by DNA content or metabolic assays 
(data not shown) in spheroids grown for 7/14 days prior to 7/14 days paclitaxel 
treatment, was significantly reduced by 40-60% (Fig. 5B). 3D reconstructions of 
CLSM images depicted reduced cell spheroid formation upon treatment with 
paclitaxel (Fig. S4A). Quantitative cluster analyses of CLSM images revealed 
formation of significantly larger clusters (>20x104 μm3) in non-treated samples, 
compared to paclitaxel-treated conditions, in which clusters remained mostly small 
(<10x104 μm3; Fig. 5C, left panel). Total cluster numbers increased significantly 
upon treatment for 7 days (Fig. 5C, right panel). Histograms including density plots 
illustrated more and smaller clusters after treatment compared to non-treated clusters 
(Fig. S4B). Further studies on the effects of paclitaxel treatment of 3D cultures 
revealed that α3/α5/β1 integrin and MMP9 expression was significantly increased 
after treatment compared to non-treated conditions (Fig. 5D). 
Ultrastructural differences of cell spheroids upon paclitaxel treatment were detected 
by TEM. No major morphological changes were observed in 3D compared to 2D 
cultures of OV-MZ-6 cells [37]. OV-MZ-6 cells within spheroids were partially 
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separated by intercellular spaces bridged by cytoplasmic interdigitations and 
hemidesmosomes. The cytoplasm was rich in mitochondria and ribosomes, whereas 
rough endoplasmatic reticulum and fat droplets were rarely observed. The nuclei were 
moderately irregular in shape and encompassed over 50% of the cell organelle. 
Spheroids of OV-MZ-6 cells (and SKOV-3 cells - data not shown) within hydrogels 
showed compact cell organisation with large lysosomes and were mostly mitotic, only 
a few were apoptotic. Upon paclitaxel treatment, mainly necrotic areas and smaller 
cell spheroids were found (Fig. 5E). 
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4. Discussion 
 
4.1. Third dimension in cell cultures 
 
Matrix-based 3D in vitro culture models are increasingly becoming essential tools in 
cancer research as they allow cell responses that more closely mimic events occurring 
in vivo during cancer formation and progression. They provide a pathophysiological 
context that more accurately replicates solid cancer microenvironments compared to 
monolayer cultures in 2D [1, 2, 9, 10]. In this context, we first examined the 
behaviour of two EOC cell types in 2D on conventional culture plastic, and in 3D 
within novel synthetic biomaterials. These matrices can be functionalised to include 
key features of naturally derived ECMs (e.g. the interaction with cells via integrin 
binding sites and the ability of proteolytically remodelling by cell-mediated 
processes). Similar to reported studies on epithelial cancer cells in 3D [15, 17] and in 
vivo observations of ovarian cancer growth [49, 56], single EOC cells embedded 
within hydrogels grew as multicellular spheroids. In contrast, in 2D, on traditional 
plastic surfaces, they formed cell monolayers (Fig. 1A, B). 
Intriguingly, both EOC cell lines displayed similar growth profiles in 2D, but in 3D 
they differed significantly. OV-MZ-6 cells grown in 3D as spheroids proliferated 
more than spheroids of SKOV-3 cells (Fig. 1C). Hence, 2D cultures approached 
confluence within the monitored time frame over 5 days and decreased proliferation, 
while slower growing cell spheroids continued to grow for 12 days (Fig. 1C) up to 28 
days (Fig. S2). Due to dramatic differences in cell organization resulting from culture 
conditions in 2D and 3D, with 3D being more close to that observed in vivo, it is 
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questionable whether plastic-based cultures may be selective enough to study cell 
behaviours. 
 
4.2. Physiological aspects of 3D cell cultures 
 
Despite the complex variables involved in the transition from 2D to 3D, the additional 
dimensionality of 3D cultures compared to 2D cultures is a crucial feature leading to 
differences in cell responses. This extra dimensionality not only influences the spatial 
organization of cell surface receptors engaged in interactions with surrounding cells 
(e.g. the development of lamellipodia (Fig. 1E, F)) and ECM [8, 52], but also induces 
the physical constraint experienced by cells in 3D [22, 28, 29]. These spatial and 
physical aspects affect the signal transduction from the outside to the inside of cells, 
and ultimately have a profound influence on gene expression and cell behaviour [8]. 
Interestingly, these cell responses have been shown to occur similarly in vivo and in 
3D rather than in 2D [40, 57, 58]. Within 3D matrix adhesions enhanced cell function 
compared to 2D (e.g. the involvement of α3/α5/β1 integrins and MMP9) was detected 
(Fig. 1D). Elevated integrin expression in EOC cell spheroids was also reported 
earlier and underlines the physiological relevance of 3D models [49, 51]. 
The more physiological 3D microenvironment caused not only formation of cell 
spheroids (diameter >50 µm), mimicking the peritoneal ascites where EOC cells exist 
as individual cells or aggregate to multicellular spheroids (diameter 50-750 µm) [49], 
but also an increase in growth rates of both EOC cell types (Fig. 1C; S2). The 
presence of keratins 8/18 supports their epithelial nature (Fig. S1). ‘Partial or 
incomplete epithelial-mesenchymal transition (EMT)’ is a common feature in EOC 
displaying a dysregulated adhesion phenotype characterized by loss of epithelial (E)-
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cadherin [59]. The EOC cells used here already have a mesenchymal phenotype as 
noted by vimentin expression (Fig. S1). This expression concurs with reports that 
serous ovarian carcinomas express vimentin in vivo, and is a characteristic of a limited 
spectrum of these carcinoma types [37]. 
 
4.3. Tunable 3D models for cell–ECM interactions 
 
The transition from 2D to 3D cultures represents a landmark step in cancer research 
towards replicating cell events occurring in vivo. Various 3D studies have shown that 
specific cell–matrix interactions influencing cancer cell behaviour and cancer 
development [4, 52, 60, 61]. Despite hallmark outcomes obtained using current gold 
standard 3D models, there is a need for 3D systems that are more reliable, 
reproducible and possess controllable characteristics [2, 4, 9, 25]. In our study, we 
used a synthetic hydrogel-based 3D platform that offers high design flexibility of 
natural matrix microenvironments. We focused on replicating three key features of the 
ECM implicated in interactions between cancer cells and their microenvironment: i) 
matrix stiffness, ii) display of cell-integrin binding sites, and iii) ability to undergo 
cell-mediated proteolytic degradation. To our knowledge, this is the first study which 
explores systematically the influence of these key features of extracellular 
microenvironments on epithelial cancer cells cultured in 3D. In contrast to naturally 
derived matrices [17, 22, 58] and (semi)-synthetic biomaterials [52, 62], each of these 
hydrogel characteristics can be manipulated independently. 
Contrary to studies using ‘overlay 3D cultures’ [22, 31, 51] or ‘3D on top assays’ 
[17], we used 3D cultures where cells were embedded within an anisotropic 
biomimetic hydrogel formed from liquid precursor solutions containing 
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homogenously dispersed single EOC cells. Consequently, cells are exposed in all 
directions to similar biomechanical and biochemical stimuli. Since functions of 
matrix-embedded cells are dependent on surrounding microenvironments, we sought 
firstly to modulate the biomaterial stiffness [35, 36, 42]. Unlike cells grown within a 
3D matrix or in tissues, cells cultured on plastic are attached to essentially rigid 
materials. Similarly, the stiffness of hydrogels altered 3D adhesions, shape and 
proliferation. With increasing material stiffness cell spheroid formation and size were 
reduced. 3D reconstructions visualized irregular and scattered cell spheroids formed 
in softer hydrogels; compact and dense cell spheroids in stiffer hydrogels (Fig. 2). Our 
results underpin published data showing morphological asymmetry and growth 
differences. Increased matrix concentrations inhibited cell spheroid growth and raised 
cell density due to enhanced resistance posed by the matrix and higher density of 
MMP-substrates recognized by cells, rather than being caused by limitations of 
nutrients or waste removal diffusion [21, 50]. Interestingly, tThese data are different 
from anotherthat of one study that showed largerincreased cell spheroid formation 
with increased matrix stiffness [22]. These differences could be However, one should 
be aware that comparisons between some 3D studies is difficult due to the use of 
different 3D culture techniques employed (e.g. type of matrices, overlay or on top vs. 
matrix-embedded cell cultures), cell lines and experimental approaches (e.g. culture 
time, biomaterial stiffness). Additionally, in contrast to the biomimetic PEG-based 
hydrogels described here, with the use of naturally derived matrices due to their 
inherent characteristics, it is often challenging to investigate the influence of the 
biological and mechanical characteristics independently and separately. In general, 
cCellular sensing towards biomaterial stiffness was reported to be consistent with a 
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role for signalling like tyrosine phosphorylation, but molecular mechanisms involved 
remain unknown [50]. 
 
4.4. Specific integrin activation 
 
Cell-integrin engagement and interactions with ECM molecules in 3D are essential in 
regulating cancer development and growth [8]. We explored the involvement of 
integrins in cell spheroid formation in 3D by specific functionalization of hydrogels 
with the prototypic cell-adhesion motif RGD. This cell integrin-binding has proven 
ability to impact on function of various cancer cells [52], including EOC cells [63]. 
Proliferation of EOC cells was significantly enhanced in RGD-functionalised 
hydrogels (Fig. 3A). In contrast to other cell types (e.g. fibroblasts [36, 42] and oral 
squamous carcinoma cells [52]), EOC cells proliferated and formed significantly 
more medium-sized clusters within non-RGD-functionalised hydrogels (Fig. 3D). 
This suggests that EOC cells are producing their own ECM (Fig. 1G, H) (e.g. 
vitronectin [64], fibronectin [56], collagen type I (data not shown)) and/or rely on 
cell–cell interactions for survival and proliferation of multicellular spheroids. 
Formation of cell-secreted ECM within spheroids reduces anti-cancer drug penetrance 
and enhances integrin-mediated pro-survival signalling [56]. 
Taken together these results not only strengthen the hypothesis that integrin activation 
is crucial in EOC progression [65, 66], but also open up new avenues to explore 
complex aspects of cancer cell–ECM interactions using this versatile 3D platform. 
Different cell integrin-binding domains singularly or in combination and/or various 
sequences of target biomolecules can be tested using a similar approach [67]. By 
integrating multiple cell types to generate pathologically more relevant cell–cell 
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interactions, the impact of cancer-associated stroma on spheroid formation and 
chemoresistance can be dissected. A 3D omental model developed by Kenny et al. 
[31] involves different cell types, ovarian cancer cells, mesothelial cells, and omental 
fibroblasts, implicated in the early steps of ovarian cancer metastasis by replicating a 
pathophysiologically cancer microenvironment. Such 3D organotypic models can 
then be used to examine expression and activity of cancer-associated proteases and 
their therapeutic inhibition [32, 54]. 
The biological mechanisms by which cell spheroids are formed and sustained as well 
as their integrin expression is poorly understood [51]. Inhibition of β1 integrin and 
MMP9 suppressed spheroid–ECM interactions in EOC cells [68, 69]. Hereby, 
interactions between α5β1 integrin and fibronectin mediate formation [49], whereas 
α2β1 integrin plays a role in disaggregation and invasion of EOC cell spheroids [51]. 
Expression of integrins and cancer-associated proteases differ in 3D compared to 2D 
[8] confirmed by our own data demonstrating significantly increased α3/α5/β1 
integrins and MMP9 expression in 3D cultures compared to 2D cultures (Fig. 1D). 
The altered α3/β1 integrin levels are not in line with other studies because spheroids 
were derived from different EOC cell lines, grown on top of agarose-coated wells 
and/or due to another detection method being used [51]. The impact of altered 
stiffness of hydrogels was even more pronounced upon RGD-incorporation 
stimulating integrin-dependent growth (Fig. 3). Integrins act as mechanoregulators on 
cell fate upon changed matrix rigidity by promoting Rho and ERK activation [22]. 
 
4.5. Cell proteolytic machinery in 3D 
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Since the biodegradability of biomaterials influences survival and migration of cell 
spheroids, hydrogels sensitive to specific and localized cell-mediated proteolytic 
degradation by MMPs were generated [48, 53, 54]. Indeed, proliferation of cell 
spheroids within MMP-sensitive hydrogels was significantly enhanced compared to 
MMP-insensitive hydrogels and blocked by a broad-spectrum MMP-inhibitor 
(GM6001) leading to smaller spheroids (Fig. 4A-C, S3F). Cell growth in MMP-
insensitive hydrogels was higher than in MMP-inhibited conditions. In MMP-
insensitive matrices fewer cell spheroids were formed than in MMP-sensitive 
hydrogels (Fig. 4A). However, the fewer cell spheroids in MMP-insensitive hydrogels 
grew bigger than in non-inhibited MMP-sensitive matrices (Fig. 4B, C). Since MMP-
inhibition is most likely not affecting or altering the cell proliferative behaviour (Fig. 
4C, S3F), these differences might be caused by unspecific and slower degradation of 
MMP-insensitive hydrogels as previously observed with other cell types [28, 29]. 
Inconsistent with other reports, only pro-MMP9 was detected in cell spheroids, even 
less than in cell monolayers (Fig. 4D; S3C), due to the embedded nature of our 3D 
cultures whereas cell spheroids grown on top of agarose-coated assays secreted active 
MMP9 [51]. In 3D omental co-cultures MMP9 was expressed by mesothelial cells 
and fibroblasts and by ovarian cancer cells once they bound to the 3D co-culture [54]. 
To further investigate the involvement of MMPs, we incubated cell monolayers with 
the MMP-inhibitor. MMP-inhibition of 2D cultures had no effect on cell proliferation 
(Fig. S3C) indicating a role of MMPs in cell spheroid formation in 3D. This result is 
supported by a report blocking cell spheroid invasion to mesothelial monolayers using 
the same MMP-inhibitor [68]. These and our studies suggest that 3D models need to 
be carefully designed to mimic specific in vivo situations. Collectively, our data 
demonstrate the possibility of investigating separately different aspects of cell–matrix 
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interactions that are important in cancer growth and progression by exploiting the 
design flexibility of the matrix characteristics offered by these biomimetic hydrogels. 
 
4.6. Chemoresistance of 3D cell cultures 
 
Typically, flat surfaces, compared to tissues or 3D systems, force cells to adapt to 
abnormal microenvironmental conditions, which can then lead to altered cell 
responses [8, 70]. Consequently, this may result in 2D being less selective than 3D 
cultures in dissecting behavioural differences among cell types and in their sensitivity 
towards chemotherapeutics as reported in our 3D study. In fact, early multicellular 
models described influences of cancer micro-regions on the responsiveness to 
cytotoxic agents [11, 16]. Landmark 3D cancer studies are in line with this 
observation and demonstrated that phenotypical differences between normal and 
malignant epithelial breast cells were observed exclusively in 3D [2, 15, 30]. EOC 
cell spheroids revealed an enhanced resistance to chemotherapeutics, including 
paclitaxel and cisplatin [41, 47, 71]. 
Here, we report that paclitaxel treatment of EOC cells in 2D cultures inhibited cell 
survival and proliferation significantly (Fig. 5A, S4C). Cell survival and proliferation 
in 3D cultures after paclitaxel treatment was reduced by 40 or 60% in conditions 
where cell spheroids were grown for 1/2 weeks prior to 1/2 weeks treatment, 
respectively, while the same treatment led to 80% reduced cell viability of cell 
monolayers. Cells grown as spheroids develop multicellular-dependent 
chemoresistance (Fig. 5B, C) as observed in vivo [49, 56]. For EOC cells, it was 
demonstrated that paclitaxel triggered apoptosis in 2D accompanied with decreased 
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Bcl-XL expression while it did not induce cell death in 3D [41]. Bcl-2 expression was 
related to paclitaxel-induced apoptosis of 2D cultures but not in 3D [71]. 
The phenomenon of cell spheroids displaying elevated chemoresistance to anti-cancer 
reagents has been attributed to several mechanisms, including a decreased penetrance 
of anti-cancer drugs, increased pro-survival signalling, and/or upregulation of genes 
conferring drug resistance. In fibroblast-derived 3D matrices differential responses of 
epithelial cancer cells grown as multicellular spheroids to cytotoxic drugs were 
described. Paclitaxel treatment led to elevated integrin expression, as shown in our 3D 
cultures (Fig. 5D), and respective signalling [20] Therefore, 3D systems can be used 
as in vitro drug evaluation tools [20, 62, 72]. 
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5. Conclusions 
 
We provide evidence that this 3D hydrogel system offers well-defined and 
reproducible extracellular microenvironments for studying pathophysiological 
processes in cancerogenesis. Both EOC cell lines embedded within hydrogels grew as 
multicellular spheroids from single cells, mimicking ovarian cancer metastases in vivo 
where cells are shed from the primary cancer and aggregate as spheroids within the 
ascites in the peritoneal cavity. Changes in extracellular microenvironment 
characteristics achieved by the systematic and independent alteration of the stiffness, 
biological and biochemical properties of these synthetic matrices tangibly and 
specifically influenced the behaviour of EOC cells cultured in 3D. Additionally, these 
multicellular spheroids have shown higher resistance to anti-cancer drugs than cell 
monolayers grown in 2D. Thus, these design features render this 3D model an 
exceptionally versatile cell culture tool. Because of their controlled and reproducible 
properties, their ability to replicate natural microenvironments, and their stability in 
long-term cultures, these bioengineered 3D matrices are suited to study specific cell–
matrix interactions implicated in cancer development as well as to screen anti-cancer 
drugs and chemoresistance. 
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Figure legends 
 
Figure 1. Differences in cell organisation and proliferation on conventional 2D 
plastic and in physiologically relevant 3D cultures. 
A. Schematic illustration (modified from [7]) of EOC cells grown in 2D as 
monolayers (left) on traditional plastic surfaces and in 3D as spheroids embedded 
within hydrogels (right). B. Both EOC cell types – OV-MZ-6, SKOV-3 – formed in 
2D (left) typical monolayers shown by phase contrast (top panel) and confocal 
(bottom panel; cell actin filaments stained with rhodamine phalloidin, nuclei with 
DAPI) microscopy images. In 3D, both EOC cell types embedded within hydrogels 
grew as spheroids imaged by phase contrast (top panel) and confocal (bottom panel, 
3D reconstruction) microscopy. Scale bars, 75 μm. C. EOC cells proliferated similar 
over 5 days when cultured in 2D as monolayers. Grown in 3D as spheroids, OV-MZ-6 
cells proliferated significantly more than SKOV-3 cells over 12 days; mean ± SEM, 4 
experiments. D. Quantitative analysis of mRNA levels normalised to 18S expression 
revealed significantly increased levels of α3/α5/β1 integrins and MMP9 in 3D 
compared to 2D (OV-MZ-6). E.-H. SEM analyses depicted multicellular spheroid 
formation of EOC cells (OV-MZ-6) within hydrogels. F. Cells within a spheroid were 
connected via the development of lamellipodia. G./H. The growth and anchorage of 
multicellular spheroids within hydrogels was supported by cell-secreted ECM. Scale 
bars, 20µm (F, G), 10µm (E, H). Statistical significance, * P<0.05, ** P<0.01, *** 
P<0.001. 
 
Figure 2. Formation and proliferation of cell spheroids in 3D as a function of 
matrix stiffnesspolymer dry mass. 
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A. Proliferation of OV-MZ-6 cell spheroids within hydrogels was decreased with 
increasing biomaterial stiffness altered by variation of the mechanical properties. This 
effect was even more pronounced when hydrogels were RGD-functionalised; mean ± 
SEM, 3 experiments. B. 3D reconstructions of CLSM images illustrated differences in 
shape and cell spheroid formation upon altered hydrogel stiffness and RGD-
functionalisation: formation of irregular and scattered cell spheroids was exclusively 
observed in softest (G’=241±19 Pa) hydrogels (lower panel). Scale bars, 100 μm. C. 
Quantitative cluster analyses showed more small/medium clusters in stiff 
(G’=1201±121 Pa) RGD-functionalised hydrogels and a trend towards larger clusters 
(P=0.07) in softer hydrogels. D. Histograms (grey columns) and density plots (black 
line) revealed total distribution of clusters; 3 experiments. Fewer and smaller clusters 
were formed in softer RGD-functionalised hydrogels. Statistical significance, ** 
P<0.01. 
 
Figure 3. Incorporation of cell integrin-binding sites within hydrogels influences 
formation and proliferation of cell spheroids. 
A. OV-MZ-6 cell spheroids proliferated significantly more within RGD-
functionalised (50 μM) hydrogels (filled symbols) compared non-RGD-functionalised 
conditions (open symbols) over 12 days; mean ± SEM, 4 experiments. B. 3D 
reconstructions of CLSM images depicted differences in formation of cell spheroids 
upon RGD-functionalisation of hydrogels: more and larger cell spheroids were 
formed upon RGD-incorporation. Scale bars, 100 μm. C. Cell morphology between 
2D and 3D cultures imaged by immunofluorescent staining by CLSM confirmed 
changed expression of α3/β1 integrins in monolayers (left panel; scale bars, 20 μm) 
and spheroids (right panel; scale bars, 100 μm). D. Quantitative cluster analyses 
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revealed significant formation of medium clusters in non-RGD-functionalised 
hydrogels (top panel). Total number of clusters was significantly enhanced upon 
RGD-incorporation within hydrogels compared to non-RGD-functionalised 
conditions. No difference in total cluster volume upon RGD-incorporation was 
detected (lower panel). E. Histograms (grey columns) and density plots (black line) 
illustrated total distribution of clusters; 3 experiments. Fewer clusters were formed in 
non-RGD-functionalised hydrogels. Statistical significance, ** P<0.01, *** P<0.001. 
 
Figure 4. Formation and proliferation of cell spheroids in 3D as a function of 
matrix biochemical characteristics. 
A. Proliferation of OV-MZ-6 cell spheroids within MMP-insensitive hydrogels was 
significantly reduced compared to MMP-sensitive hydrogels over 12 days. MMP-
inhibition (GM6001, 20 µM in culture media) led to significantly decreased 
proliferation of cell spheroids within MMP-sensitive hydrogels; mean ± SEM, 3 
experiments. B. 3D reconstructions of CLSM images depicted influence of MMP-
sensitivity of hydrogels and MMP-inhibition on cell spheroid formation: more and 
larger cell spheroids were formed upon MMP-sensitivity; after MMP-inhibition fewer 
and smaller cell spheroids were observed. Scale bars, 100 μm. C. Quantitative cluster 
analyses revealed significant formation of smaller clusters upon MMP-inhibition and 
medium/large clusters in non-inhibited MMP-sensitive hydrogels. Significant larger 
clusters were formed in MMP-insensitive hydrogels compared to MMP-sensitive 
hydrogels (top panel). MMP-sensitivity and MMP-inhibition significantly influenced 
total number and volume of clusters: fewer clusters were formed in MMP-insensitive 
hydrogels and after MMP-inhibition, smaller clusters detected in MMP-inhibition of 
MMP-sensitive hydrogels (lower panel). D. Histograms (grey columns) and density 
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plots (black line) illustrated total distribution of clusters; 3 experiments. MMP-
sensitivity of hydrogels led to more clusters compared to MMP-insensitive hydrogels; 
MMP-inhibition caused less and smaller clusters. Statistical significance, ** P<0.01, 
*** P<0.001. 
 
Figure 5. Paclitaxel treatment of EOC cells grown in 2D as monolayers and in 3D 
as spheroids. 
A. Survival of OV-MZ-6 cell monolayers in 2D as a function of paclitaxel 
concentration (0.01-100 nmol/L) showed a dramatic decline from 10nM; mean ± 
SEM, 4 experiments. B. Survival of OV-MZ-6 cells spheroids within hydrogels was 
significantly decreased after paclitaxel (10 nmol/L) treatment; however, to a lesser 
extent compared to cell monolayers at the same concentration; mean ± SEM, 3 
experiments. C. Quantitative cluster analyses revealed significantly larger clusters in 
non-treated conditions; in paclitaxel-treated samples clusters remained mostly small. 
Upon paclitaxel treatment a significantly increased number and decreased volume of 
clusters was detected; mean ± SEM, 3 experiments. D. Quantitative mRNA analysis 
revealed significantly increased levels of α3/α5/β1 integrins and MMP9 upon 
normalisation to 18S levels in cell spheroids in 3D upon exposure to paclitaxel. E. 
TEM analyses showed morphological differences of cell spheroids after treatment: 
without treatment defined cell structures and cell–cell contacts within spheroids were 
visible (N-nucleus, ER-endoplasmatic reticulum, AC-apoptotic cell, TJ-tight 
junctions), after treatment necrotic areas and smaller cell spheroids were detected 
(NEC-necrotic cell). Scale bars, overview 1 μm, zoom 0.2 μm. Statistical significance, 
* P<0.05, ** P<0.01, *** P<0.001. 
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Supplementary figure 1. Characterisation of EOC cells grown in 2D as 
monolayers and in 3D as spheroids by morphological markers. 
A. Expression of epithelial markers (keratin 8/18, E-cadherin) and mesenchymal 
markers (vimentin) were detected via RT-PCR, with 18S as loading control, in both 
OV-MZ-6 (top panel) and SKOV-3 (bottom panel) EOC cell types grown in 2D as 
monolayers and in 3D as spheroids. B. Immunocytochemistry confirmed the 
expression of epithelial and mesenchymal markers in both OV-MZ-6 (top panel) and 
SKOV-3 (bottom panel) EOC cell lines, sustained in adhesive culture over the course 
of this study, depicted as overlay staining; no primary antibody served as control (cell 
actin filaments stained with rhodamine phalloidin, nuclei with DAPI, morphological 
marker with respective primary and Alexa488-conjugated secondary antibodies). 
Scale bars, 50 μm. 
 
Supplementary figure 2. Long-term culture and proliferation of cell spheroids in 
3D grown within biomimetic hydrogels. 
A. EOC cells were grown as spheroids within hydrogels up to 28 days and visualized 
by phase contrast microscopy. Scale bars, 100 μm. B. 3D reconstructions of CLSM 
images depicted shape and growth of cell spheroids embedded within hydrogels. 
Whereas OV-MZ-6 cells grew slightly less at 21 to 28 days in 3D culture, SKOV-3 
cells formed large (diameter >300 μm) spheroids. Scale bars, 100 μm. C. When 
grown as spheroids, OV-MZ-6 cells reached their maximum proliferation after 12 
days, whereas SKOV-3 proliferated less but continuously up to 28 days; mean ± 
SEM, 4 experiments. 
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Supplementary figure 3. Influence of RGD-incorporation and MMP-sensitivity 
of biomimetic hydrogels on formation of cell spheroids. 
A. Quantitative cluster analyses revealed no difference upon altered polymer dry mass 
of hydrogels without RGD peptides, but a trend towards smaller clusters (P=0.08) in 
stiff (G’=1201±121 Pa) hydrogels. B. Proliferation of SKOV-3 cell spheroids was 
increased within RGD-functionalised (50 μM) hydrogels (filled symbols) compared 
non-RGD-functionalised conditions (open symbols) over 12 days; mean ± SEM, 4 
experiments. 3D reconstructions of CLSM images depicted differences in formation 
of SKOV-3 cell spheroids upon RGD-functionalisation of hydrogels: more and larger 
cell spheroids were formed upon RGD-incorporation. Scale bars, 100 μm. C. MMP-
inhibition of OV-MZ-6 cell monolayers grown in 2D had no effect on their 
proliferation; mean ± SEM, 3 experiments. D. Quantitative measurement of 
endogenous (pro) and total (pro+active) MMP9 production in conditioned media of 
OV-MZ-6 cell spheroids grown within MMP-sensitive hydrogels showed a reduction 
of total MMP9 independent from RGD-incorporation compared to cell monolayers. 
Endogenous MMP9 levels did not change upon 3D culture. Upon 2D culture minor 
amounts of active MMP9 were produced. E. Zymography confirmed pro-MMP9 in 
conditioned media of OV-MZ-6 cell spheroids within hydrogels independent from 
MMP-sensitivity. Pro-MMP9 level was reduced after MMP-inhibition (GM6001, 20 
μM in culture media). F. SEM analyses confirmed changes of OV-MZ-6 cell spheroid 
formation upon MMP-sensitivity of hydrogels and MMP-inhibition. Scale bars, 
overview 500 μm (inserted panel), zoom 10 μm. 
 
Supplementary figure 4. Effects of paclitaxel treatment on EOC cells grown as 
spheroids within biomimetic hydogels. 
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A. 3D reconstructions of CLSM images depicted less cell spheroid formation within 
hydrogels after treatment up to 28 days. Scale bars, 100 μm. B. Histograms (grey 
columns) and density plots (black line) illustrated total distribution of clusters; 3 
experiments. Paclitaxel treatment led to more and smaller clusters compared to non-
treated conditions. 
 
Supplementary figure 5. Live cell imaging of survival and formation of cell 
spheroids in 3D cultures. 
Time-lapse microscopy of live cell spheroid survival and formation of OV-MZ-6 (A, 
movie) and SKOV-3 (B, movie) cells cultured within hydrogels over 6 days revealed 
that multicellular spheroids were formed from single cells. Scale bars, 100 μm. 
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Tables 
 
Supplementary table 1. Primers used for RT-qPCR and PCR conditions. 
Annealing temperature used for all primers was 60°C. 
 
Primers Sequence (5’-3’) Cycles 
α3 integrin forward TACGTGCGAGGCAATGACCTA 40 
α3 integrin reverse TTTGGGGGTGCAGGATGAAGCT  
α5 integrin forward CATTTCCGAGTCTGGGCCAA 40 
α5 integrin reverse TGGAGGCTTGAGCTGAGCTT  
β1 integrin forward AGGTGGTTTCGATGCCATCAT 40 
β1 integrin reverse AAGTGAAACCCGGCATCTGTG  
MMP9 forward TCGTGGTTCCAACTCGGTTT 40 
MMP9 reverse GCGGCCCTCGAAGATGA  
keratin 8 forward CTGGGATGCAGAACATGAGTATTC 35 
keratin 8 reverse GTAGCTGAGGCCGGGGCTTGT  
keratin 18 forward GAGACGTACAGTCCAGTCCTTGG 35 
keratin 18 reverse CCACCTCCCTCAGGCTGTT  
E-cadherin forward GCCCATTTCCTAAAAACCTGG 35 
E-cadherin reverse TTGGATGACACAGCGTGAGAG  
Vimentin forward TGGAAGAGAACTTTGCCGTTG 35 
Vimentin reverse AAGGTGACGAGCCATTTCCTC  
18S forward GATCCATTGGAGGGCAAGTCT 35 
18S reverse CCAAGATCCAACTACGAGCTTTTT  
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